Skip to the page

Data / Form D filings / Cardiosense, Inc.

Cardiosense, Inc.: Form D filings

Cardiosense, Inc., a health care company in Chicago, IL, filed 2 Form D notices with the SEC between 2022 and 2026. The latest, on August 24, 2026, reports $26.1 million sold of a $42 million offering to 30 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
400 N. ABERDEEN ST. SUITE 1050, Chicago, IL, 60642
Phone
(312) 725-2211
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1957335

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 24, 2026New notice$42,012,230$26,137,050$15,875,18030Aug 7, 2026sec.gov
Dec 9, 2022New notice$17,650,986$9,084,327$8,566,65928Nov 29, 2022sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Eric MeizlishExecutive Officer, Director
Andrew Michael CarekExecutive Officer
Daniel GottliebDirector
Bimal ShahDirector
Jeffrey TrostDirector
Lauren Pierce FlickingerDirector
Omer Tolga InanExecutive Officer, Director

Other health care companies in Illinois that filed recently

Every Form D from the week of Aug 24, 2026 · All recent filings in Illinois · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Cardiosense, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.